Navigation Links
Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
Date:7/14/2011

this goal in a modular manner and we look forward to generating data from this study using a multi-antigen vaccine, which we expect in the first quarter of 2012."

Positive data from Inovio's first universal influenza vaccine program clinical study

Inovio's VGX-3400X targets the pandemic influenza subtype H5N1. The vaccine consists of three distinct DNA plasmids coded for a consensus hemagglutinin (HA) antigen derived from different H5N1 virus strains; a consensus neuraminidase (NA) antigen derived from different N1 sequences; and a consensus nucleoprotein (NP) fused to a small portion of the m2 protein (m2E) based on a broader cross-section of influenza viruses in addition to H5N1 and H1N1.

In this first proof of principle study of Inovio's universal flu vaccine program, VGX-3400X was delivered with IM electroporation using Inovio's CELLECTRA® electroporation device. The primary objectives of this clinical trial were to assess safety and tolerability. The secondary objective was the measurement of antigen-specific T cell and antibody responses, including binding and hemagglutination inhibition (HI) responses.

The study assessed a total of 60 healthy volunteers, 30 in the US and 30 in Korea (in a separate, parallel clinical trial sponsored by Inovio affiliate VGX International). Three dose cohorts of 10 subjects were each given two injections of 0.2 mg, 0.67 mg, or 2.0 mg of each plasmid at months 0 and 1.

In the study, VGX-3400X was found to be generally safe and well tolerated at all dose levels. There were no vaccine-related serious adverse events. Reported adverse events and injection site reactions were mild to moderate and required no treatment.

Inovio tested for antibody responses against the target antigens and observed high levels of binding antibodies in 26 of 27 evaluated subjects (96%). Antibodies were generated against all three antigens, as tested by the enzyme-linked immunosorbent assay (ELISA). P
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Inovio Pharmaceuticals Announces Transition of Avtar Dhillon to Non-Executive Chairman of the Board
2. Inovio Pharmaceuticals to Present at Scientific & Industry Conferences
3. Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011
4. Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011
5. Inovio Pharmaceuticals Market-Leading Intellectual Property Recognized by MDB Capital Award
6. Inovio Pharmaceuticals to Present at Investor Conferences
7. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
8. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
9. Inovio Pharmaceuticals to Present at Scientific Conferences
10. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
11. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , England and PITTSBURGH , May ... a leading global pharmaceutical company, today announced that Mylan ... the Bernstein Strategic Decisions Conference, Friday, May 29, 2015 ... can access a live webcast of the presentation via ... http://mylan.com/investors . An archived version will also be available ...
(Date:5/26/2015)... May 26, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... focused on developing therapeutics that address unmet medical ... George Elston will present at the ... 28, 2015Time: , 4:00 PM EDTLocation: , The ... , www.juniperpharma.com, under  ,Investor, or  click ...
(Date:5/26/2015)... Fla. , May 26, 2015  Advanzeon ... subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS"), (sometimes, ... that effective immediately Mr. Matt Capps ... Public Relations Consultant to the Company,s Community Outreach ... position in Advanzeon.  This engagement provides for Mr. ...
Breaking Medicine Technology:Juniper Pharmaceuticals to Present at Investor Conference on May 28, 2015 2Advanzeon Solutions, Inc. And Its Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Welcome Major League Baseball Great Matt Capps As Senior Public Relations Consultant 2Advanzeon Solutions, Inc. And Its Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Welcome Major League Baseball Great Matt Capps As Senior Public Relations Consultant 3Advanzeon Solutions, Inc. And Its Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Welcome Major League Baseball Great Matt Capps As Senior Public Relations Consultant 4
... an icon of scientific skincare development, continues to provide award ... Kinerase Restructure Firming Eye Cream has ... Beauty Awards, appearing in the magazine,s October 2011 issue. ... over 236 beauty products were chosen as winners across a ...
... WOODLANDS, Texas, Sept. 27, 2011 In today,s ... provide excellent, efficient care while ensuring the ongoing ... Specialty Health , a division of McKesson ... Select Program , it is now offering Innovative ...
Cached Medicine Technology:Kinerase Wins Allure Best of Beauty Award for 2nd Consecutive Year 2New McKesson Specialty Health Program Helps Providers Thrive In Today's Quality-Driven Healthcare Environment 2New McKesson Specialty Health Program Helps Providers Thrive In Today's Quality-Driven Healthcare Environment 3
(Date:5/26/2015)... (PRWEB) May 27, 2015 Readers who ... may find help in author Chester Litvin ’s ... : Litvin’s Code” (published by Trafford Publishing). , Litvin, ... approach for stimulating the brain. This book will guide ... reeducate their sensory brain cells . He shares ...
(Date:5/26/2015)... 2015 This summer, ChopChop: The Fun ... communities at key events in Greater Boston with a custom ... copies of ChopChop Magazine, healthy snacks and other giveaways to ... , “We want to get our message of eating and ... memorable and fun way,” explains Sally Sampson, Founder of ChopChop. ...
(Date:5/26/2015)... In God’s Unstoppable Favor, Grace Vidrine Sibley ... an unforgettable story of how God has blessed her ... black student to desegregate Evangeline Parish School District in ... treated harshly by a few teachers, and shot at ... with Dr. Martin Luther King, Jr. ignited a renewed ...
(Date:5/26/2015)... 2015 Dermatologic surgeons performed nearly 9.5 ... to survey results released today by the American Society ... treatments and several cosmetic categories, 2014 totals were 21 ... overall compared to 2013 figures. , For the ... as the most-performed procedure (3.08 million) by ASDS members ...
(Date:5/26/2015)... York (PRWEB) May 26, 2015 The ... http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who were ... the litigation’s June 11th Science Day. According to an ... of Louisiana, on May 21st, topics to be addressed ... drug, the use of blood test based testing with ...
Breaking Medicine News(10 mins):Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 3Health News:Award-Winning Cooking Magazine for Kids Takes Healthy Cooking and Eating to the Streets with One-of-a-Kind Bike Campaign 2Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 4Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4
... school staff , SATURDAY, Aug. 22 (HealthDay News) -- There ... asthma can prepare for flu season and the new school ... the best and first line of defense against any type ... your mouth when coughing or sneezing," Dr. Norman H. Edelman, ...
... , , SOLON, ... of the U.S. marketplace, Nestle USA is pleased to announce that ... week. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090818/SF63053-a ) , (Photo: ... for both retail partners and consumers to identify the new batch ...
... gene promoters in fecal DNA showed promise as a ... to a new study published online August 21 in ... Because many patients are reluctant to undergo ... development of nonintrusive screening tests is desirable. Especially in ...
... , WASHINGTON, Aug. 21 Teen pop idol ... Jonas Brothers, will address a National Press Club luncheon on Monday, August ... 13 will discuss his personal fight against diabetes and efforts to raise ... , (Logo: http://www.newscom.com/cgi- b in/prnh/20080917/NPCLOGO ...
... , , , ... in the home and office bottled water, filtration and office coffee delivery ... Susan G. Komen for the Cure(R), the world,s largest breast cancer advocacy ... DS Waters will make a $30.00 donation to Komen for the Cure ...
... , SILVER SPRING, Md., Aug. 21 ... for the Ethical Treatment of Animals (PETA) promoting vegetarianism at the ... displays an image of an overweight woman in a bikini, with ... Vegetarian ." This ad is an unmistakable example of stigma and ...
Cached Medicine News:Health News:Going Back to School With Asthma Takes Extra Work 2Health News:Updated With Photos: NESTLE(R) TOLL HOUSE(R) Re-launches With 'New Batch' Label 2Health News:Fecal DNA methylation detects gastric and colorectal cancers 2Health News:Nick Jonas to Speak on Juvenile Diabetes at National Press Club August 24 2Health News:DS Waters of America, Inc. Partners With Susan G. Komen for the Cure(R) 2Health News:DS Waters of America, Inc. Partners With Susan G. Komen for the Cure(R) 3Health News:DS Waters of America, Inc. Partners With Susan G. Komen for the Cure(R) 4Health News:The Obesity Society Calls Billboard Campaign Offensive and Off-Target 2
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
Medicine Products: